Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance

Enveric Biosciences IncTrade
Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 19757.8× Enveric Biosciences Inc's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.

ENVBMFG
Market Cap
$6.69M$132.18B
Volume
41,1413,264,662
Sector
HealthFinancials
52-Week High
$10.80$11.45
52-Week Low
$1.27$6.09
Typical Hold Time
14 Days0 Days
Enterprise Value
-$1.60M$35.48T
Dividend Yield
—1.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.

The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.

Mizuho Financial Group Inc. Sponosred ADR (Japan)

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENVB

No sentiment data available yet.

MFG
100% Buy0% Sell
Avg holding period · 0 Days

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB →

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →